+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Alnylam Pharmaceuticals Inc - logo
Alpha-1 Antitrypsin Deficiency (A1AD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency (A1AD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • May 2023
  • 88 Pages
  • Global
From
Eg5 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Eg5 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Kinesin Spindle Protein Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Kinesin Spindle Protein Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • July 2024
  • 98 Pages
  • Global
From
Huntington's Disease Treatment Market - Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027) - Product Thumbnail Image

Huntington's Disease Treatment Market - Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)

  • Report
  • August 2022
  • 106 Pages
  • Global
From
Transthyretin Amyloidosis Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Transthyretin Amyloidosis Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 88 Pages
  • Global
From
Thalidomide Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Thalidomide Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • Report
  • February 2024
  • 117 Pages
  • Global
From
Huntington's Disease Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Huntington's Disease Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 84 Pages
  • Global
From
Inclisiran - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

Inclisiran - Emerging Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
RNA Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

RNA Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • February 2024
  • 118 Pages
  • Global
From
Familial Amyloid Neuropathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Familial Amyloid Neuropathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 59 Pages
  • Global
From
Huntingtons Disease Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Huntingtons Disease Therapeutics Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2022
  • 84 Pages
  • Global
From
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 168 Pages
  • Global
From
Transthyretin - Pipeline Review, H2 2020 - Product Thumbnail Image

Transthyretin - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 116 Pages
  • Global
From
Alpha-1 Antitrypsin Deficiency (A1AD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency (A1AD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • April 2022
  • 124 Pages
  • Global
From
Alnylam Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Alnylam Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • November 2024
  • 50 Pages
From
Alnylam Pharmaceuticals 2023 Full Year Operating and Financial Review - SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry - Product Thumbnail Image

Alnylam Pharmaceuticals 2023 Full Year Operating and Financial Review - SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Pharmaceutical Industry

  • SWOT Analysis
  • December 2023
  • Global
From
Comprehensive Report on Alnylam Pharmaceuticals Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Alnylam Pharmaceuticals Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Alnylam Pharmaceuticals Inc (ALNY) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Alnylam Pharmaceuticals Inc (ALNY) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • May 2024
  • 58 Pages
From
2022 Alnylam Pharmaceuticals Half-Year Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry - Product Thumbnail Image

2022 Alnylam Pharmaceuticals Half-Year Review and Outlook - Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry

  • SWOT Analysis
  • June 2022
  • Global
From
Loading Indicator